Research Study on Whether a Combination of 2 Medicines (NNC0194 0499 and Semaglutide) Works in People With Non-alcoholic Steatohepatitis (NASH)

NCT05016882 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

698

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-alcoholic Steatohepatitis

Interventions

DRUG: NNC0194 0499 50 mg/mL
DRUG: Placebo (NNC0194-0499)
DRUG: Semaglutide 3 mg/mL
DRUG: Semaglutide placebo
DRUG: NNC0174 0833 10 mg/mL
DRUG: NNC0174 0833 placebo

Sponsor

Novo Nordisk A/S